Abbott’s Next‑Generation Cardiomems™ Remote Heart Failure Monitoring Reader Received FDA Approval to Enhance Patient Experience and Help Detect Disease Progression
On 27 February 2026, Abbott announced that the U.S. Food and Drug Administration (FDA) had approved the company’s CardioMEMS™ HERO device, a next-generation pulmonary artery (PA) pressure reader, to support the care of people living with heart failure. The reader featured new design elements aimed at empowering patients and clinicians with daily insights to detect and manage heart failure progression. Abbott subsequently began the commercial release of the CardioMEMS HERO reader in the United State...